SWATI PATEL: Open Payments
NPI 1033503560 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 58 payments from 18 companies in 2025. Trend: 2023 $1,337 · 2024 $1,244 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $155 |
| ABBVIE INC. | 11 | $155 |
| Abbott Laboratories | 6 | $112 |
| Amgen Inc. | 6 | $93 |
| Corcept Therapeutics | 5 | $87 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| Lilly USA, LLC | 3 | $52 |
| IBSA Pharma Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: VRAYLAR, FREESTYLE LIBRE 3, Korlym, Wegovy, OTEZLA, Kerendia, MOUNJARO, NUCALA.
Industry payments across NJ — which companies pay providers there.
